Watchlist

Watchlist
Advanced Accelerator Applications S... (AAAP)
Advanced Accelerator Applications S... (AAAP)
Premarket analyst action - healthcare
Aethlon Medical (NASDAQ: AEMD ) initiated with Buy rating and $3 (209% upside) price target by H.C. Wainwright. More news on: Aethlon Medical, Inc., Aimmune Therapeutics, Ablynx NV, Healthcare stocks news, Read more …
Advanced Accelerator reports Q3 results
Advanced Accelerator (NASDAQ: AAAP ): Q3 EPS of -0.26 More news on: Advanced Accelerator Applications, Earnings news and commentary, Healthcare stocks news, Read more …
Biotech Forum Daily Digest: Possible Buyout Scenarios For Neos Therapeutics
Solitude is fine but you need someone to tell that solitude is fine . - Honore De Balzac The biotech sector Monday added slightly to its gains from Friday after last week's decline on poor earning results from industry stalwarts like Celgene ( CELG ) . Once again small caps in th…
Premarket Gainers as of 9:05 am
SPCB +23% on Q3 result . More news on: SuperCom, Ltd., CalAtlantic Group, Inc., Lennar Corporation, Stocks on the move, Read more …
Wall Street Breakfast: Bitcoin Sets New All-Time High
Just a week after pushing past $6,000, bitcoin broke through the $6,300 mark for the first time late Sunday, taking gains this year to well over 500% . Investors appear to be shrugging off some of the negative news associated with last week's "hard fork," which resulted in the cre…
Novartis scoops up Advanced Accelerator
Helping strengthen its oncology businesses, Novartis (NYSE: NVS ) has announced a $3.9B deal to buy Advanced Accelerator Applications (NASDAQ: AAAP ). More news on: Novartis AG, Advanced Accelerator Applications, Merger & acquisition news, Stocks on the move, Healthcare stocks news, …
3 Things In Biotech You Should Learn Today: September 30, 2017
Welcome to another edition of "3 Things In Biotech You Should Learn Today," a daily digest dedicated to helping you keep pace with the fast-moving world of pharmaceutical and biotechnology research. Tesaro's Chinese partner initiates trials for its PARP inhibitor Tesaro (TSRO) made a big s…
Your Daily Pharma Scoop: Celgene's CELMoD Potential, Allergan's Senate Troubles, Abbott Approval Surge
This abridged Daily Scoop is published by Avisol Capital Partners, which runs the physician-managed Total Pharma Tracker healthcare investment research service on Seeking Alpha Marketplace. Analysis of top Seeking Alpha coverage: Celgene, by Dr Udaya Maiya, MD, Oncologis…
Bloomberg: Novartis considering deal for Advanced Accelerator
Advanced Accelerator Applications (NASDAQ: AAAP ) +11.6% AH following a Bloomberg report that Novartis (NYSE: NVS ) is considering a deal for the company . More news on: Advanced Accelerator Applications, Novartis AG, Healthcare stocks news, Merger & acquisition news, Stocks on…
After Hours Gainers / Losers
Top gainers, as of 5.25 p.m.: AAAP +15.7% . CHMA +8.2% . VNET +3.6% . More news on: Advanced Accelerator Applications, Chiasma, 21Vianet Group, Stocks on the move, Read more …
3 Things In Biotech You Should Learn Today: September 10, 2017
Welcome to another edition of "3 Things In Biotech You Should Learn Today," a daily digest dedicated to helping you keep pace with the fast-moving world of pharmaceutical and biotechnology research! BioMarin has mixed findings in Sanfilippo B syndrome BioMarin (BMRN) has no shortage of mar…
Advanced Accelerator Applications S... (AAAP)
Advanced Accelerator Applications S... (AAAP)